Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_4
2
50%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 42 (50.0%)

Trials by Status

completed125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_4

Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section

NCT05928871
completedphase_2

Ulipristal Acetate for Use in Early Pregnancy Loss

NCT05216952
unknownphase_4

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

NCT05124314
unknownearly_phase_1

Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

NCT05001061

Clinical Trials (4)

Showing 4 of 4 trials
NCT05928871Phase 4

Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section

Unknown
NCT05216952Phase 2

Ulipristal Acetate for Use in Early Pregnancy Loss

Completed
NCT05124314Phase 4

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

Unknown
NCT05001061Early Phase 1

Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4